zzlangerhans’ Activity

Tue Sep 1

CAPS Outperform Pitch

zzlangerhans wrote about Sunesis Pharmaceuticals, Inc. (SNSS) . 11:38 PM

SNSS Outperform

One of the most frustrating things about the biopharma sector is that logic is often completely insufficient as a basis for a profitable trade. Despite applying logic to my analysis of Sunesis and being completely correct about the outcome of every [more]

Mon Aug 24

Caps Pick

zzlangerhans made a pick in CAPS. 1:34 PM

Sunesis Pharmaceuticals, Inc. (SNSS) will Outperform the S&P 500

Sun Aug 16

CAPS Outperform Pitch

zzlangerhans wrote about Karyopharm Therapeutics (KPTI) . 2:28 PM

KPTI Outperform

Lots of knowledgeable commenters have been rising to the defense of Karyopharm subsequent to the stock's recent decimation. The plunge came after the company revealed a disproportionate number of cases of sepsis in the selinexor arm of the SOPRA [more]

Wed Aug 12

Caps Pick

zzlangerhans made a pick in CAPS. 5:07 PM

Karyopharm Therapeutics (KPTI) will Outperform the S&P 500

Tue Aug 11

CAPS Underperform Pitch

zzlangerhans wrote about AQUINOX PHARMACEUT (AQXP) . 1:37 AM

AQXP Underperform

On my recent green thumb pitch on Aquinox, I pointed out that the market cap was well below cash and the company still had at least one shot left on goal despite failure of two midstage trial in a row. I followed that up with a 5000 share buy, and [more]

CAPS Outperform Pitch

zzlangerhans wrote about TRACON Pharmaceuticals, Inc. (TCON) . 1:21 AM

TCON Outperform

I had decent success with my last Tracon trade, so I'm keeping a close eye on the stock as it bounces erratically between 10 and 14. I think the stock is a fairly good risk/reward bet at the low end of that range because the market cap is only 140M, [more]

Sun Aug 9

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for IMMU. 3:46 PM

Bought 5000 shares for zzporte at 1.8.

CAPS Underperform Pitch

zzlangerhans wrote about Vermillion, Inc. (VRML) . 2:15 PM

VRML Underperform

Vermillion is one of those mystifying companies that seems to exist mainly for the purpose of raising money through issuance of secondary offerings. One strange fact about the stock market is that a company which has no viable product and steadily [more]

CAPS Outperform Pitch

zzlangerhans wrote about ARCA Biopharma, Inc. (ABIO) . 1:53 PM

ABIO Outperform

It's always fun to drop a green thumb on a member of my trifecta of futility: Arca, Cel-Sci, and Opexa. Each of these companies is conducting an enormous late stage trial which they don't have a fraction of the funds to complete. The entertainment [more]

Fri Aug 7

Caps Pick

zzlangerhans made a pick in CAPS. 12:55 PM

AQUINOX PHARMACEUT (AQXP) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:46 AM

TRACON Pharmaceuticals, Inc. (TCON) will Outperform the S&P 500

Tue Aug 4

Caps Pick

zzlangerhans made a pick in CAPS. 8:20 AM

Vermillion, Inc. (VRML) will Underperform the S&P 500

Fri Jul 31

Caps Pick

zzlangerhans made a pick in CAPS. 3:35 PM

ARCA Biopharma, Inc. (ABIO) will Outperform the S&P 500

CAPS Outperform Pitch

zzlangerhans wrote about ESPERION THERAPEUTICS INC (ESPR) . 2:59 PM

ESPR Outperform

I'm way out of my depth with Esperion. They've clearly got an active drug in ETC-1002 with a great shot at strong phase III data and FDA approval. The question at this point is whether the commercial potential of ETC-1002 justifies the 1.8B valuation [more]

Thu Jul 30

CAPS Outperform Pitch

zzlangerhans wrote about Immunomedics, Inc. (IMMU) . 10:42 PM

IMMU Outperform

Lately my CAPS score and my real life accounts have been taking a drubbing as some of my long-term favorite stocks have taken a drubbing while a number of my most overvalued shorts have become twice as overvalued. One of the most painful aspects of [more]

Caps Pick

zzlangerhans made a pick in CAPS. 2:04 PM

Immunomedics, Inc. (IMMU) will Outperform the S&P 500

Mon Jul 27

CAPS Outperform Pitch

zzlangerhans wrote about Sunesis Pharmaceuticals, Inc. (SNSS) . 12:00 AM

SNSS Outperform

One of the most frustrating things about the biopharma sector is that logic is often completely insufficient as a basis for a profitable trade. Despite applying logic to my analysis of Sunesis and being completely correct about the outcome of every [more]

Fri Jul 24

Caps Pick

zzlangerhans made a pick in CAPS. 2:29 PM

ESPERION THERAPEUTICS INC (ESPR) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 10:51 AM

Sunesis Pharmaceuticals, Inc. (SNSS) will Outperform the S&P 500

Thu Jul 23

CAPS Outperform Pitch

zzlangerhans wrote about XOMA Limited (XOMA) . 9:35 PM

XOMA Outperform

When I dropped my red thumb on Xoma years ago, I didn't know what Baker Brothers was. I just saw the company as a perma-disappointer experiencing an inexplicable and temporary rebound before eventually resuming their downward spiral to bankruptcy. [more]

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.77
Player Rank 173 out of 75189
Score 6084.21
Score Change Today -305.02
Accuracy 82.23%
Active Picks 169
Total Picks 2115
Best Pick BDSI (+1070.42)
Worst Pick PCYC.DL (-2886.09)
Average Score per Pick 2.88
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts